SLQT · Selectquote, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.53B | $1.32B | $1.00B | $764.04M | $937.82M | $531.51M |
| Cost of Revenue | $630.34M | $405.00M | $225.96M | $466.81M | $270.71M | $167.40M |
| Gross Profit | $896.25M | $916.77M | $776.88M | $297.24M | $667.10M | $364.12M |
| R&D | - | - | - | - | - | - |
| SG&A | $164.44M | $141.04M | $63.11M | $89.84M | $63.11M | $35.28M |
| Total Operating Expenses | $1.46B | $1.26B | $928.42M | $1.02B | $709.68M | $377.46M |
| D&A | $20.46M | $25.00M | $27.88M | $24.72M | $16.14M | $7.99M |
| Operating Income | $68.50M | $64.55M | $11.58M | ($346.01M) | $200.07M | $132.33M |
| Interest Expense | $79.39M | $93.55M | $80.61M | $43.59M | $29.32M | $25.76M |
| Income Tax | $931.0K | $5.06M | ($10.60M) | ($92.30M) | $34.80M | $25.02M |
| Net Income | $47.58M | ($34.13M) | ($58.54M) | ($297.50M) | $131.05M | $81.15M |
| EPS - Basic | $0.14 | ($0.20) | ($0.35) | ($1.81) | $0.80 | ($0.16) |
| EPS - Diluted | $0.01 | ($0.20) | ($0.35) | ($1.81) | $0.79 | ($0.16) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $32.40M | $42.69M | $83.16M | $141.00M | $286.45M | $570.0K |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | $8.76M | $5.57M | $176.0K | - | - |
| Accounts Payable | $59.20M | $36.59M | $27.58M | $24.77M | $34.08M | $7.63M |
| Current Assets | $341.04M | $332.92M | $363.22M | $402.77M | $493.44M | $513.83M |
| Total Assets | $1.25B | $1.19B | $1.22B | $1.29B | $1.43B | $406.94M |
| Current Liabilities | $212.91M | $174.59M | $137.26M | $113.51M | $108.82M | $33.22M |
| Long-term Debt | $316.59M | $637.48M | $664.63M | $698.42M | $459.04M | $11.03M |
| Total Liabilities | $673.84M | $877.11M | $872.28M | $898.95M | $758.98M | $143.69M |
| Stockholders' Equity | $351.14M | $316.80M | $346.97M | $391.11M | $674.89M | $262.45M |
| Retained Earnings | ($222.19M) | ($269.77M) | ($235.64M) | ($177.10M) | $128.25M | $200.45M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($11.67M) | $15.24M | ($19.38M) | ($338.31M) | ($115.44M) | ($61.78M) |
| Investing Cash Flow | ($11.31M) | ($14.85M) | ($9.13M) | ($42.58M) | ($64.02M) | ($51.37M) |
| Financing Cash Flow | $17.36M | ($40.86M) | ($29.34M) | $235.43M | $97.04M | $481.45M |
| CapEx | $2.19M | $3.38M | $1.45M | $24.80M | $14.91M | $9.45M |
| Free Cash Flow | ($13.86M) | $11.85M | ($20.82M) | ($363.11M) | ($130.35M) | ($71.22M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 58.7% | 69.4% | 77.5% | 38.9% | 71.1% | 68.5% |
| Operating margin | 4.5% | 4.9% | 1.2% | -45.3% | 21.3% | 24.9% |
| EBITDA margin | 5.8% | 6.8% | 3.9% | -42.1% | 23.1% | 26.4% |
| Net margin | 3.1% | -2.6% | -5.8% | -38.9% | 14.0% | 15.3% |
| Free cash flow margin | -0.9% | 0.9% | -2.1% | -47.5% | -13.9% | -13.4% |
| FCF / Net income | -0.29 | -0.35 | 0.36 | 1.22 | -0.99 | -0.88 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 10.8% | 10.7% | 6.3% | 11.8% | 6.7% | 6.6% |
| Effective tax rate | 1.9% | - | - | - | 21.0% | 23.6% |
| Return on assets | 3.8% | -2.9% | -4.8% | -23.1% | 9.1% | 19.9% |
| Return on equity | 13.5% | -10.8% | -16.9% | -76.1% | 19.4% | 30.9% |
| Return on invested capital | 10.1% | 5.3% | 0.9% | -25.1% | 13.9% | 37.0% |
| Liquidity | ||||||
| Current ratio | 1.60 | 1.91 | 2.65 | 3.55 | 4.53 | 15.47 |
| Quick ratio | 1.60 | 1.86 | 2.61 | 3.55 | 4.53 | 15.47 |
| Cash ratio | 0.15 | 0.24 | 0.61 | 1.24 | 2.63 | 0.02 |
| Leverage | ||||||
| Debt / Equity | 0.90 | 2.01 | 1.92 | 1.79 | 0.68 | 0.04 |
| Debt / Assets | 0.25 | 0.53 | 0.55 | 0.54 | 0.32 | 0.03 |
| Debt / EBITDA | 3.56 | 7.12 | 16.84 | - | 2.12 | 0.08 |
| Interest coverage | 0.9x | 0.7x | 0.1x | -7.9x | 6.8x | 5.1x |
| Equity multiplier | 3.56 | 3.77 | 3.51 | 3.30 | 2.12 | 1.55 |
| Liabilities / Assets | 0.54 | 0.73 | 0.72 | 0.70 | 0.53 | 0.35 |
| Efficiency | ||||||
| Asset turnover | 1.22 | 1.11 | 0.82 | 0.59 | 0.65 | 1.31 |
| Inventory turnover | - | 46.24 | 40.59 | 2652.32 | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | 8d | 9d | 0d | - | - |
| Days payable outstanding | 34d | 33d | 45d | 19d | 46d | 17d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 238.0x | - | - | - | 24.4x | - |
| P / B | 1.2x | 1.5x | 0.9x | 1.0x | 4.7x | 9.4x |
| P / S | 0.3x | 0.4x | 0.3x | 0.5x | 3.4x | 4.6x |
| EV / EBITDA | 8.1x | 11.8x | 22.9x | - | 15.5x | 17.7x |
| Growth | ||||||
| Revenue growth (YoY) | 15.5% | 31.8% | 31.3% | -18.5% | 76.4% | - |
| Revenue CAGR (3y) | 26.0% | 12.1% | 23.6% | - | - | - |
| Revenue CAGR (5y) | 23.5% | - | - | - | - | - |
| Gross profit growth (YoY) | -2.2% | 18.0% | 161.4% | -55.4% | 83.2% | - |
| Operating income growth (YoY) | 6.1% | 457.3% | - | - | 51.2% | - |
| Net income growth (YoY) | - | 41.7% | 80.3% | - | 61.5% | - |
| EPS growth (YoY) | - | 42.9% | 80.7% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 94.3% | -178.6% | -83.0% | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 10.8% | -8.7% | -11.3% | -42.0% | 157.1% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-06-30.
Business segments
$1.53B totalHealthcare Services Segment$742.71M · 48.4%
Senior Segment$600.39M · 39.1%
Life Segment$172.98M · 11.3%
All Other Revenue$18.03M · 1.2%
Product / service
$2.28B totalService$797.84M · 35.0%
Pharmacy$728.75M · 32.0%
Medicare Advantage$518.03M · 22.7%
Final Expense$78.17M · 3.4%
Term$74.69M · 3.3%
Product And Service Other$70.97M · 3.1%
Other Senior$11.40M · 0.5%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.53
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✗Operating cash flow positive
- ✓ROA improved YoY
- ✗Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Insurance Agents, Brokers & Service
Comparing SelectQuote against the 5 most active filers in the same SIC group.